Rheumatoid arthritis: tocilizumab monotherapy and adalimumab monotherapy go head-to-head in RA
- PMID: 23567454
- DOI: 10.1038/nrrheum.2013.49
Rheumatoid arthritis: tocilizumab monotherapy and adalimumab monotherapy go head-to-head in RA
Comment on
-
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18. Lancet. 2013. PMID: 23515142 Clinical Trial.
References
-
- Lancet. 2013 May 4;381(9877):1541-50 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources